Skip to main content
Equibles
RMD logo

RMD · Resmed Inc · Debt

Track RMD — free

Use RMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$219.95 -1.10 (-0.50%) At close · Sep 9
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$31.73B
Shares
144.25M

Debt Profile

Completed filing coverage through Jan 30, 2020 · latest terminal result Sep 1, 2026

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Latest reported total
USD 660,000,000
As of Jun 30, 2026
Tracked instruments
0
Stable identities across filings
Annual baseline
Jun 30, 2026
Latest approved 10-K total
Reported total debt history
As of Reported label Amount Source
2026-06-30 total outstanding debt USD 660,000,000 10-K filed 2026-08-13
Our leverage and debt service obligations could adversely affect our business. As of June 30, 2026, our total outstanding debt was $660 million and we may incur additional indebtedness in the future. Our indebtedness could have adverse consequences, including:
2025-06-30 total consolidated debt USD 700,000,000 10-K filed 2025-08-08
Our leverage and debt service obligations could adversely affect our business. As of June 30, 2025, our total consolidated debt was $0.7 billion and we may incur additional indebtedness in the future.
2024-06-30 total consolidated debt USD 700,000,000 10-K filed 2024-08-09
Our leverage and debt service obligations could adversely affect our business. As of June 30, 2024, our total consolidated debt was $0.7 billion and we may incur additional indebtedness in the future.
2023-06-30 total consolidated debt USD 1,400,000,000 10-K filed 2023-08-11
Our leverage and debt service obligations could adversely affect our business. As of June 30, 2023, our total consolidated debt was $1.4 billion and we may incur additional indebtedness in the future.
2022-06-30 our total consolidated debt USD 800,000,000 10-K filed 2022-08-12
Our leverage and debt service obligations could adversely affect our business. As of June 30, 2022, our total consolidated debt was $0.8 billion and we may incur additional indebtedness in the future, including as a result of our pending acquisition of MEDIFOX DAN, which is expected to close during our fiscal year 2023.
8 filing observations remain unmatched and are excluded from instrument histories.
Debt data is being processed. Please check back later.
8 filings have incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Key facts CIK 943819 CUSIP 761152107 13F (30d) 416 filings 411 filers Visit website Investor relations